MedTrace Logo

The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic

NCT04416061 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2510

Last updated 2024-02-28

No results posted yet for this study

Summary

Hong Kong public healthcare system is facing tremendous pressure under the COVID-19 pandemic. As the virus spread in Hong Kong, Hong Kong Sanatorium \& Hospital (HKSH) is one of the first private hospitals which immediately provide reliable and rapid COVID-19 test -- Reverse Transcription Polymerase Chain Reaction (RT-PCR). Early provision of the RT-PCR screening test for COVID-19 not only facilitates identification of COVID-19 but also contains the spread of the virus in the community and frontline medical staff.

Since description of role of private hospital in Hong Kong amid COVID-19 pandemic is lacking, this study will describe COVID-19 screening algorithm and methodology. A retrospective analysis on clinical characteristics, laboratory findings as well as outcome of patients who underwent COVID-19 test in HKSH is also performed.

Conditions

Interventions

DIAGNOSTIC_TEST

COVID 19 Diagnostic Test

COVID 19 Diagnostic Test

Sponsors & Collaborators

  • Hong Kong Sanatorium & Hospital

    lead INDUSTRY

Principal Investigators

  • Jonpaul Sze Tsing Zee, MBChB · Hong Kong Sanatorium & Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04416061 on ClinicalTrials.gov